In a post-New Year’s Eve broadcast, Dr. Daniel Griffin and Vincent Racaniello of "This Week in Virology" (TWiV) have delivered…
Read More
TWiV 1285: Encapsidating Viruses 2025
The podcast "This Week in Virology" (TWiV) recently released its 1285th episode, offering a comprehensive review of compelling virology themes…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin Explores Alarming Shifts in Childhood Immunization and Enduring Public Health Challenges
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
TWiV 1287: Ancient herpesviruses and modern dementia
Virologists Uncover Deep History of Human Herpesviruses and Explore Shingles Vaccine’s Impact on Dementia In a wide-ranging discussion broadcast on…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent episode of the highly regarded scientific podcast "This Week in Virology" (TWiV), host Vincent Racaniello and clinical…
Read More
TWiV 1289: Building a Better Hepatitis B Trap
This Week in Virology (TWiV) episode 1289 delves into two significant breakthroughs in virology: the intricate mechanisms by which the…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Diverse Medical Topics from Screwworm to Scientific Advocacy
In a comprehensive clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, alongside host Vincent…
Read More
Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio
Biogen, a global biotechnology company renowned for its pioneering work in neuroscience, has announced a significant strategic acquisition of Apellis…
Read More
TWiV 1291: A Foot in the Door for Cytomegalovirus
This episode of "This Week in Virology" (TWiV) delves into two critical advancements in virology: the emergence of a neurovirulent…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
The United States’ withdrawal from the World Health Organization (WHO) and proposed changes to vaccine mandates have ignited significant debate…
Read More
